Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FGF
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
PF-05231023
/ Pfizer
BI 3006337
/ Boehringer Ingelheim
AUR-109
/ Orion Corp, Dr. Reddy’s
H3B-6527
/ Eisai
LY2405319
/ Eli Lilly
LY2874455
/ Eli Lilly
LY3025876
/ Eli Lilly
SKI-G-801
/ Oscotec
XL228
/ Exelixis
lenvatinib gel suspension
(AIV007) / AiViva BioPharma
nintedanib inhaled
(AP02) / Avalyn Pharma
ABSK061
/ Abbisko
ABSK121
/ Abbisko
ASP5878
/ Astellas
B1344
/ Tasly
BMS-986171
/ BMS
CPL304110
/ Celon Labs
CVBT-141H
/ Venturis Therapeutics
DR10624
/ Huadong Medicine
DS-1123
/ Daiichi Sankyo
EOC317
/ EddingPharm
ET0111
/ Etern Biopharma
ICP-105
/ InnoCare
INCB62079
/ Incyte
KIN-3248
/ Kinnate Biopharma
LOXO-435
/ Eli Lilly
LY3076226
/ Eli Lilly
PRN1371
/ Sanofi
R1530
/ Roche
SY-4798
/ Shouyao Holdings
SYHX2005
/ CSPC Pharma
TT-00434
/ TransThera Biosci
TTHX1114 eye drops
/ Trefoil Therapeutics
TYRA-200
/ Tyra Biosci
U3-1784
/ Daiichi Sankyo
Undisclosed FGF-1 Parkinson therapeutic
/ Zhittya Genesis Medicine
alofanib
(RPT835) / R-Pharm
aprutumab
(BAY 1179470) / Bayer
aprutumab ixadotin
(BAY1187982) / Bayer
